Dapagliflozin Supplier-Buyer Network — Trade Flow Analysis

Name: Dapagliflozin Supplier-Buyer Trade Network Dataset — 254+ Indian Exporters, 25+ Importers, 113+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Dapagliflozin supplier network, Dapagliflozin buyers, pharmaceutical export India, Dapagliflozin trade data

TransData Nexus

Dapagliflozin

India Pharmaceutical Trade Intelligence

$49.5M254 Suppliers113 CountriesHS 30049099

ExportsIndia → CANADA25.9%India → IRAQ17.2%

ImportsGERMANY → India$59.4K BRAZIL → India$38.8K

#1 Supplier: AJANTA PHARMA

Who Supplies Dapagliflozin? Top Manufacturers & Buyers 2026 — AJANTA PHARMA LIMITED Leads | TransData Nexus | TransData Nexus

1AJANTA PHARMA LIMITED

AJANTA PHARMA LIMITED is the first-largest Dapagliflozin exporter from India, with a market share of 15.6% and a total export value of $7.7M across 103 shipments. Their average shipment value of $75.1K is above the market average of $9.7K, suggesting premium or bulk contract pricing.

AJANTA PHARMA LIMITED serves 5 named buyers in our database. AWAMEDICA is the dominant customer, accounting for 61.6% of this supplier's tracked business. Top customers include:

• AWAMEDICA — $4.8M across 63 shipments (61.6% of this supplier's total exports)

• AWAMEDICA PESHAWA STREET — $1.4M across 18 shipments (17.5% of this supplier's total exports)

• AYSA DENIZCILIK TIC. TUR. VE SAN. A — $846.5K across 11 shipments (10.9% of this supplier's total exports)

• PLANET PHARMA SA — $459.9K across 6 shipments (5.9% of this supplier's total exports)

• ROZ LOJISTIK ULUSLARARASI TASIMACIL — $317.4K across 4 shipments (4.1% of this supplier's total exports)

Key Insight: AJANTA PHARMA LIMITED's per-shipment value of $75.1K is 675% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.

2ALEMBIC PHARMACEUTICALS LIMITED

ALEMBIC PHARMACEUTICALS LIMITED is the second-largest Dapagliflozin exporter from India, with a market share of 11.2% and a total export value of $5.6M across 95 shipments. Their average shipment value of $58.5K is above the market average of $9.7K, suggesting premium or bulk contract pricing.

ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. GROUPE AFFI is the dominant customer, accounting for 62.0% of this supplier's tracked business. Top customers include:

• GROUPE AFFI — $3.4M across 59 shipments (62.0% of this supplier's total exports)

• PHARMASCIENCE INC. — $674.0K across 12 shipments (12.1% of this supplier's total exports)

• MANTRA DISTRIBUTIONS INC — $670.6K across 11 shipments (12.1% of this supplier's total exports)

• PHARMASCIENCE INC. — $544.4K across 9 shipments (9.8% of this supplier's total exports)

• 1177 55e AvenueDorva — $222.8K across 4 shipments (4.0% of this supplier's total exports)

Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $58.5K is 503% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.

3INVENTIA HEALTHCARE LIMITED

INVENTIA HEALTHCARE LIMITED is the third-largest Dapagliflozin exporter from India, with a market share of 7.4% and a total export value of $3.7M across 111 shipments. Their average shipment value of $33.0K is above the market average of $9.7K, suggesting premium or bulk contract pricing.

INVENTIA HEALTHCARE LIMITED serves 5 named buyers in our database. JAMP PHARMA CORPORATION. is the dominant customer, accounting for 52.1% of this supplier's tracked business. Top customers include:

• JAMP PHARMA CORPORATION. — $1.9M across 58 shipments (52.1% of this supplier's total exports)

• JAMP PHARMA CORPORATION. — $860.5K across 26 shipments (23.5% of this supplier's total exports)

• UNILAB, INC. — $581.8K across 18 shipments (15.9% of this supplier's total exports)

• DKSH MALAYSIA SDN BH — $160.0K across 5 shipments (4.4% of this supplier's total exports)

• HOVID BHD — $155.1K across 5 shipments (4.2% of this supplier's total exports)

Key Insight: INVENTIA HEALTHCARE LIMITED's per-shipment value of $33.0K is 241% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.

4MICRO LABS LIMITED

MICRO LABS LIMITED is the fourth-largest Dapagliflozin exporter from India, with a market share of 5.8% and a total export value of $2.9M across 442 shipments. Their average shipment value of $6.5K is below the market average of $9.7K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MICRO NOVA PHARMACEUTICALS IND — $1.0M across 158 shipments (35.8% of this supplier's total exports)

• SUED & FARGESA — $626.4K across 97 shipments (21.9% of this supplier's total exports)

• BROWN AND BURK PHILI — $488.5K across 76 shipments (17.1% of this supplier's total exports)

• AL-KAWKAB SCIENTIFIC — $388.1K across 60 shipments (13.6% of this supplier's total exports)

• PHILLIPS PHARMACEUTI — $329.2K across 51 shipments (11.5% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (442 shipments) at a per-shipment value of $6.5K, indicating a broad distribution network with many smaller, regular orders.

5CIPLA LIMITED

CIPLA LIMITED is the fifth-largest Dapagliflozin exporter from India, with a market share of 5.4% and a total export value of $2.7M across 96 shipments. Their average shipment value of $27.9K is above the market average of $9.7K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. SINO UNIVERSAL PHARMACEUTICAL CO is the dominant customer, accounting for 53.8% of this supplier's tracked business. Top customers include:

• SINO UNIVERSAL PHARMACEUTICAL CO — $1.4M across 52 shipments (53.8% of this supplier's total exports)

• SINO UNIVERSAL PHARMACEUTICAL CO — $386.6K across 14 shipments (14.4% of this supplier's total exports)

• SINO UNIVERSAL PHARMACEUTICAL CO — $347.5K across 12 shipments (13.0% of this supplier's total exports)

• SINO UNIVERSAL PHARMACEUTICAL CO — $316.8K across 11 shipments (11.8% of this supplier's total exports)

• WORLDWIDE HEALTHCARE — $188.5K across 7 shipments (7.0% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $27.9K is 188% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.

6MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the fifth-largest Dapagliflozin exporter from India, with a market share of 5.4% and a total export value of $2.7M across 34 shipments. Their average shipment value of $78.1K is above the market average of $9.7K, suggesting premium or bulk contract pricing.

MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. MYLAN IRELAND LTD is the dominant customer, accounting for 94.0% of this supplier's tracked business. Top customers include:

• MYLAN IRELAND LTD — $2.5M across 32 shipments (94.0% of this supplier's total exports)

• ALGORITHM SAL — $63.1K across 1 shipments (2.4% of this supplier's total exports)

• MACLEODS PHARMACEUTI — $56.1K across 1 shipments (2.1% of this supplier's total exports)

• ALGORITHM — $20.4K across 0 shipments (0.8% of this supplier's total exports)

• SIN PHYU KYUN COMPAN — $20.0K across 0 shipments (0.8% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $78.1K is 706% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.

1Canada

Canada ranks as the first-largest destination for Dapagliflozin imports from India, with a total trade value of $12.8M across 228 shipments — representing a 25.9% share of all Dapagliflozin exports. The average shipment value of $56.2K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Dapagliflozin importers in Canada: GROUPE AFFI is the largest buyer, accounting for 27.0% ($3.5M) of this market's total imports.

• GROUPE AFFI — $3.5M (27.0% of Canada's total)

• JAMP PHARMA CORPORATION — $2.3M (17.8% of Canada's total)

• AURO PHARMA INC — $1.3M (10.4% of Canada's total)

Key Insight: Canada's per-shipment average of $56.2K (480% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Dapagliflozin imports from India.

Primary Market

Secondary Market

2Iraq

Iraq ranks as the second-largest destination for Dapagliflozin imports from India, with a total trade value of $8.5M across 79 shipments — representing a 17.2% share of all Dapagliflozin exports. The average shipment value of $108.0K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Dapagliflozin importers in Iraq: AWAMEDICA is the largest buyer, accounting for 58.1% ($5.0M) of this market's total imports.

• AWAMEDICA — $5.0M (58.1% of Iraq's total)

• AWAMEDICA PESHAWA STREET — $1.4M (15.8% of Iraq's total)

• AYSA DENIZCILIK TIC. TUR. VE SAN. A — $846.5K (9.9% of Iraq's total)

Key Insight: Iraq's per-shipment average of $108.0K (1014% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Iraq is a key market for Dapagliflozin imports from India.

Primary Market

Secondary Market

3China

China ranks as the third-largest destination for Dapagliflozin imports from India, with a total trade value of $2.8M across 19 shipments — representing a 5.6% share of all Dapagliflozin exports. The average shipment value of $145.2K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Dapagliflozin importers in China: SINO UNIVERSAL PHARMACEUTICAL CO is the largest buyer, accounting for 52.3% ($1.4M) of this market's total imports.

• SINO UNIVERSAL PHARMACEUTICAL CO — $1.4M (52.3% of China's total)

Key Insight: China's per-shipment average of $145.2K (1398% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

China is a key market for Dapagliflozin imports from India.

Primary Market

Secondary Market

4Netherlands

Netherlands ranks as the fourth-largest destination for Dapagliflozin imports from India, with a total trade value of $2.5M across 10 shipments — representing a 5.0% share of all Dapagliflozin exports. The average shipment value of $249.7K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Dapagliflozin importers in Netherlands: MYLAN IRELAND LTD is the largest buyer, accounting for 100.0% ($2.5M) of this market's total imports.

• MYLAN IRELAND LTD — $2.5M (100.0% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $249.7K (2475% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Dapagliflozin imports from India.

Primary Market

Secondary Market

5Philippines

Philippines ranks as the fifth-largest destination for Dapagliflozin imports from India, with a total trade value of $2.4M across 4 shipments — representing a 4.8% share of all Dapagliflozin exports. The average shipment value of $593.7K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Dapagliflozin importers in Philippines: UNILAB, INC. is the largest buyer, accounting for 24.5% ($581.8K) of this market's total imports.

• UNILAB, INC. — $581.8K (24.5% of Philippines's total)

Key Insight: Philippines's per-shipment average of $593.7K (6024% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Dapagliflozin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Dapagliflozin.
2.Flow Mapping: 254 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 5,104 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 113 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

5,104 Verified Shipments

254 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Dapagliflozin

Dapagliflozin

Who Supplies Dapagliflozin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Dapagliflozin — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Dapagliflozin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Dapagliflozin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1AJANTA PHARMA LIMITED

2ALEMBIC PHARMACEUTICALS LIMITED

3INVENTIA HEALTHCARE LIMITED

4MICRO LABS LIMITED

5CIPLA LIMITED

6MACLEODS PHARMACEUTICALS LTD

From Indian Factories to Global Pharmacies — How Dapagliflozin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Dapagliflozin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Canada

2Iraq

3China

4Netherlands

5Philippines

People Also Ask — Dapagliflozin Supplier & Trade Network

Dapagliflozin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology